Biotechnology
Compare Stocks
2 / 10Stock Comparison
ELAB vs HOFV
Revenue, margins, valuation, and 5-year total return — side by side.
Entertainment
ELAB vs HOFV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Entertainment |
| Market Cap | $49K | $2M |
| Revenue (TTM) | $-1M | $17M |
| Net Income (TTM) | $-7M | $-63M |
| Gross Margin | 72.8% | 63.0% |
| Operating Margin | -75.7% | -158.0% |
| Total Debt | $0.00 | $249M |
| Cash & Equiv. | $4M | $432K |
ELAB vs HOFV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 23 | May 26 | Return |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | 100 | 0.0 | -100.0% |
| Hall of Fame Resort… (HOFV) | 100 | 9.6 | -90.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ELAB vs HOFV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ELAB has the current edge in this matchup, primarily because of its strength in growth exposure and sleep-well-at-night.
- Rev growth 44.1%, EPS growth 86.0%, 3Y rev CAGR 13.4%
- Lower volatility, beta 4.01, current ratio 3.36x
- Beta 4.01, current ratio 3.36x
HOFV is the clearest fit if your priority is long-term compounding.
- -99.8% 10Y total return vs ELAB's -100.0%
- -50.0% vs ELAB's -99.7%
- -17.6% ROA vs ELAB's -44.6%, ROIC -6.7% vs -82.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 44.1% revenue growth vs HOFV's -12.1% | |
| Quality / Margins | -253.1% margin vs HOFV's -366.2% | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -50.0% vs ELAB's -99.7% | |
| Efficiency (ROA) | -17.6% ROA vs ELAB's -44.6%, ROIC -6.7% vs -82.7% |
ELAB vs HOFV — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ELAB leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HOFV and ELAB operate at a comparable scale, with $17M and -$1M in trailing revenue. Profitability is closely matched — net margins range from -2.5% (ELAB) to -3.7% (HOFV). On growth, HOFV holds the edge at -33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | -$1M | $17M |
| EBITDAEarnings before interest/tax | -$4M | -$10M |
| Net IncomeAfter-tax profit | -$7M | -$63M |
| Free Cash FlowCash after capex | -$7M | -$11M |
| Gross MarginGross profit ÷ Revenue | +72.8% | +63.0% |
| Operating MarginEBIT ÷ Revenue | -75.7% | -158.0% |
| Net MarginNet income ÷ Revenue | -2.5% | -3.7% |
| FCF MarginFCF ÷ Revenue | -2.2% | -64.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | -45.8% | -33.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +100.0% | -2.0% |
Valuation Metrics
ELAB leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $49,114 | $2M |
| Enterprise ValueMkt cap + debt − cash | -$4M | $251M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | -0.04x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.02x | 0.11x |
| Price / BookPrice ÷ Book value/share | 0.01x | 0.03x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
Evenly matched — ELAB and HOFV each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
ELAB delivers a -78.4% return on equity — every $100 of shareholder capital generates $-78 in annual profit, vs $-2 for HOFV. On the Piotroski fundamental quality scale (0–9), ELAB scores 4/9 vs HOFV's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -78.4% | -2.1% |
| ROA (TTM)Return on assets | -44.6% | -17.6% |
| ROICReturn on invested capital | -82.7% | -6.7% |
| ROCEReturn on capital employed | -33.7% | -7.9% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 |
| Debt / EquityFinancial leverage | — | 3.45x |
| Net DebtTotal debt minus cash | -$4M | $249M |
| Cash & Equiv.Liquid assets | $4M | $432,174 |
| Total DebtShort + long-term debt | $0 | $249M |
| Interest CoverageEBIT ÷ Interest expense | -17.68x | -1.04x |
Total Returns (Dividends Reinvested)
HOFV leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HOFV five years ago would be worth $47 today (with dividends reinvested), compared to $0 for ELAB. Over the past 12 months, HOFV leads with a -50.0% total return vs ELAB's -99.7%. The 3-year compound annual growth rate (CAGR) favors HOFV at -63.1% vs ELAB's -98.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -98.4% | 0.0% |
| 1-Year ReturnPast 12 months | -99.7% | -50.0% |
| 3-Year ReturnCumulative with dividends | -100.0% | -95.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.5% |
| 10-Year ReturnCumulative with dividends | -100.0% | -99.8% |
| CAGR (3Y)Annualised 3-year return | -98.7% | -63.1% |
Risk & Volatility
HOFV leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HOFV is the less volatile stock with a -0.48 beta — it tends to amplify market swings less than ELAB's 4.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOFV currently trades 38.9% from its 52-week high vs ELAB's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.01x | -0.48x |
| 52-Week HighHighest price in past year | $1236.48 | $0.90 |
| 52-Week LowLowest price in past year | $1.62 | $0.24 |
| % of 52W HighCurrent price vs 52-week peak | +0.2% | +38.9% |
| RSI (14)Momentum oscillator 0–100 | 36.7 | 43.5 |
| Avg Volume (50D)Average daily shares traded | 10.4M | 0 |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
ELAB leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). HOFV leads in 2 (Total Returns, Risk & Volatility). 1 tied.
ELAB vs HOFV: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is ELAB or HOFV a better buy right now?
For growth investors, PMGC Holdings Inc.
(ELAB) is the stronger pick with 44. 1% revenue growth year-over-year, versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — ELAB or HOFV?
Over the past 5 years, Hall of Fame Resort & Entertainment Company (HOFV) delivered a total return of -99.
5%, compared to -100. 0% for PMGC Holdings Inc. (ELAB). Over 10 years, the gap is even starker: HOFV returned -99. 8% versus ELAB's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — ELAB or HOFV?
By beta (market sensitivity over 5 years), Hall of Fame Resort & Entertainment Company (HOFV) is the lower-risk stock at -0.
48β versus PMGC Holdings Inc. 's 4. 01β — meaning ELAB is approximately -937% more volatile than HOFV relative to the S&P 500.
04Which is growing faster — ELAB or HOFV?
By revenue growth (latest reported year), PMGC Holdings Inc.
(ELAB) is pulling ahead at 44. 1% versus -12. 1% for Hall of Fame Resort & Entertainment Company (HOFV). On earnings-per-share growth, the picture is similar: PMGC Holdings Inc. grew EPS 86. 0% year-over-year, compared to 27. 2% for Hall of Fame Resort & Entertainment Company. Over a 3-year CAGR, ELAB leads at 1340% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — ELAB or HOFV?
PMGC Holdings Inc.
(ELAB) is the more profitable company, earning -253. 1% net margin versus -263. 4% for Hall of Fame Resort & Entertainment Company — meaning it keeps -253. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ELAB leads at -75. 7% versus -139. 9% for HOFV. At the gross margin level — before operating expenses — ELAB leads at 72. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — ELAB or HOFV?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is ELAB or HOFV better for a retirement portfolio?
For long-horizon retirement investors, Hall of Fame Resort & Entertainment Company (HOFV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
48)). PMGC Holdings Inc. (ELAB) carries a higher beta of 4. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HOFV: -99. 8%, ELAB: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between ELAB and HOFV?
These companies operate in different sectors (ELAB (Healthcare) and HOFV (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: ELAB is a small-cap high-growth stock; HOFV is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.